Welcome to
Medios Solutions Stuttgart
The range of services for GMP compounding of patient-specific therapies at Medios Solutions Stuttgart includes not only cytostatics and antibody solutions, but also ophthalmics. Another focus of this location is manual, aseptic filling and finishing of injectable products for clinical studies.
Future in the Portfolio
Medios Solutions Stuttgart is part of the network of the Medios Group across Germany, with six certified facilities for the complex manufacturing of patient-specific therapies in state-of-the-art cleanroom labs. It takes specialized procedures, which we implement with first-class equipment, qualified personnel, and strictly monitored workflows. We uphold the highest standards in quality, safety, and adherence to deadlines, working according to the strict guidelines of Good Manufacturing Practice (GMP).
Medios Solutions Stuttgart holds the manufacturing license under §13 of the German Medicines Act (AMG), as well as the wholesale license under §52a AMG. Our range of services extends from cytostatic preparations to antibody solutions and ophthalmics. A special focus is on manual, aseptic filling and finishing materials for trials in small-scale batches ranging from 1 to 3,000 units for use in clinical studies (fill & finish service).
Our strategically planned storage and logistics system, along with the network within the Medios Group across Germany allows us to act quickly and flexibly address the needs of our customers.
We offer
- cytostatic preparations
- antibody solutions
- ophthalmic products
- clinical investigational medicinal products
(fill & finish service) - other parenteral products
Network that Empowers
Medios strives to be a pioneer in individualized medicine, collaborating with pharmacies, medical specialists, clinics, pharmaceutical companies, and all other stakeholders in the healthcare system, to ensure that people everywhere receive the most innovative pharmacotherapies quickly and safely. We pursue this ambitious goal consistently on multiple levels:
To begin with, through close collaboration between our regional sites and partners across our nationwide supply network, we ensure the highest level of security of patient care in the field of specialized medicinal products. Today, in Germany we are already able to provide patient-specific therapies and specialized medicines within 60 minutes, if required. We aim to expand this capability across Europe in the future.
At the same time, with our leading Specialty Pharma expertise, we’re a strong innovation partner, offering research companies and other collaborators groundbreaking solutions for the efficient implementation of new individualized therapies.
As a Specialty Pharma expert for patient-specific therapies, we have the solution for your individual requirements and provide comprehensive advice on all pharmaceutical, logistics, and billing-related matters.
Expertise meets customer focus
– Every order is a promise
We look forward to getting to know you.
Dr. Lena Edalat
Management
